Medtronic Guardian Connect System with In Pen and Smart Devices

This is a study of the Guardian Connect system which is a real-time continuous glucose monitoring system known as a CGM. The participants will use smart insulin pens or insulin pens with smart caps for all of their daily injections.
Clinical Description:
The purpose of this study is to collect sensor, insulin In Pen dosing, sleep, activity and food/meal data for a minimum of 90 days of device wear.
Target Age/Sex:
2 - 80 Years of Age, Male & Female
Participants will receive at no cost: study product, study materials and study-specific procedures.
Study Length:
90 Days
Information Request

Information Request

To request additional information please call 208-522-6005 or email or complete the form below.